Prospective phase II trial of alternating intravesical Bacillus Calmette-Guerin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

Journal of Surgical Oncology

Volumn 74, Issue 3, 2000, Pages 181-184

  Bazarbashi, S ^a   Raja, M A ^a   El Sayed, A ^a   Ezzat, A ^a   Ibrahim, E ^a   Kattan, S ^a   Kardar, A ^a   Peracha, A ^a   Lindstedt, E ^a   Hanash, K ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

BCG; Bladder neoplasms; Carcinoma transitional cell; Interferon alpha

Indexed keywords

ALPHA2B INTERFERON; BCG VACCINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DRUG EFFICACY; FOLLOW UP; HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TREATMENT PLANNING;

ADMINISTRATION, INTRAVESICAL; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0033881448     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200007)74:3<181::AID-JSO3>3.0.CO;2-F     Document Type: Article

References (20)

1. Current perspectives on diagnosis and treatment of superficial bladder cancer
2. Superficial bladder cancer: Progression and recurrence
3. Prognostic factors in superficial bladder tumors. A study of the European organization for research on the treatment of cancer: Genitourinary Tract Cancer Cooperative Group
4. Intravesical therapy for superficial bladder cancer
5. Bacillus Calmette-Guerin immunotherapy - Techniques and results
6. Complications of Bacillus Calmette-Guerin immunotherapy
7. Immunotherapeutic alternatives in superficial bladder cancer
8. Combination immunotherapy of murine transitional cell cancer using BCG and an Interferon-inducing pyrimidine
9. Urological malignancy II - Urothelial tumors
10. Carcinoma in situ
11. Therapy of superficial bladder cancer
12. Markers of prognosis in superficial bladder cancer
13. A randomized trial of intravesical doxorubicin and immunotherapy with Bacillus Calmette-Guerin for transitional cell carcinoma of the bladder
14. Intravesical 4'-epidoxorubicin (epirubicin) vs. Bacillus Calmette-Guerin. A controlled prospective study on the prophylaxis of superficial bladder cancer
15. 1 superficial bladder cancer with intravesical Bacillus Calmette-Guerin therapy
16. Long term results of intravesical therapy for superficial bladder cancer
17. Bacillus Calmette-Guerin therapy alters the progression of superficial cancer
18. Alpha interferon in superficial bladder cancer: A Northern California oncology group study
19. A randomized controlled study of intravesical α-2b-interferon in carcinoma in situ of the bladder
20. BCG treatment of superficial transitional cell carcinoma